In Alzheimer’s disease (AD), MMP-2 might be assumed to have a protective role [76], and in MS, active MMP-2 was associated with the remission phase of the disease, suggesting a role of this enzyme in the termination of MS neuroinflammation [77]. This evidence concerns the gene MMP2 and early-onset autosomal dominant Alzheimer disease.